These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20566420)

  • 1. Characterization of quinolone resistance in Escherichia coli strains of animal origin from Italy.
    Forcella C; Alessiani A; Perilli M; Zilli K; Di Giannatale E; Amicosante G
    J Chemother; 2010 Jun; 22(3):165-8. PubMed ID: 20566420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Tamang MD; Nam HM; Chae MH; Kim SR; Gurung M; Jang GC; Jung SC; Lim SK
    Foodborne Pathog Dis; 2012 Dec; 9(12):1057-63. PubMed ID: 23186547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle.
    Jesse TW; Englen MD; Pittenger-Alley LG; Fedorka-Cray PJ
    J Appl Microbiol; 2006 Apr; 100(4):682-8. PubMed ID: 16553723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
    Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
    J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characterization of quinolone resistance mechanisms in commensal Escherichia coli isolated from slaughter animals in Poland, 2009-2012.
    Wasyl D
    Microb Drug Resist; 2014 Dec; 20(6):544-9. PubMed ID: 25051094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level of quinolone resistance in Escherichia coli from healthy chicken broilers.
    Kmet V; Kmetová M
    Folia Microbiol (Praha); 2010 Jan; 55(1):79-82. PubMed ID: 20336509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
    Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
    Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter coli isolates derived from chickens in Senegal: Diversity, genetic exchange with Campylobacter jejuni and quinolone resistance.
    Kinana AD; Cardinale E; Bahsoun I; Tall F; Sire JM; Breurec S; Garin B; Saad-Bouh Boye C; Perrier-Gros-Claude JD
    Res Microbiol; 2007 Mar; 158(2):138-42. PubMed ID: 17258435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
    Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone resistance from a transferable plasmid.
    Martínez-Martínez L; Pascual A; Jacoby GA
    Lancet; 1998 Mar; 351(9105):797-9. PubMed ID: 9519952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
    Orden JA; Ruiz-Santa-Quiteria JA; Cid D; Díez R; Martínez S; de la Fuente R
    J Antimicrob Chemother; 2001 Sep; 48(3):421-4. PubMed ID: 11533010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007.
    Huang SY; Dai L; Xia LN; Du XD; Qi YH; Liu HB; Wu CM; Shen JZ
    Foodborne Pathog Dis; 2009 Dec; 6(10):1203-9. PubMed ID: 19735206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antimicrobial resistance and resistance genes in faecal Escherichia coli isolates recovered from healthy pets.
    Costa D; Poeta P; Sáenz Y; Coelho AC; Matos M; Vinué L; Rodrigues J; Torres C
    Vet Microbiol; 2008 Feb; 127(1-2):97-105. PubMed ID: 17870255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
    Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
    J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
    Chaniotaki S; Giakouppi P; Tzouvelekis LS; Panagiotakos D; Kozanitou M; Petrikkos G; Avlami A; Vatopoulos AC;
    Clin Microbiol Infect; 2004 Jan; 10(1):75-8. PubMed ID: 14706091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
    Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.